title: Antibody targeting as a thrombolytic strategy.
authors.affiliation: Harvard School of Public Health, Boston, Massachusetts 02115.
authors.forename: E
authors.initials: E
authors.lastname: Haber
authors.forename: C
authors.initials: C
authors.lastname: Bode
authors.forename: G R
authors.initials: GR
authors.lastname: Matsueda
authors.forename: G L
authors.initials: GL
authors.lastname: Reed
authors.forename: M S
authors.initials: MS
authors.lastname: Runge
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D000906:Antibodies; D000911:Antibodies, Monoclonal; D004337:Drug Carriers; D005337:Fibrin / Q000276:immunology; D006801:Humans; D008969:Molecular Sequence Data; D010960:Plasminogen Activators / Q000008:administration & dosage* / Q000627:therapeutic use*; D017433:Protein Structure, Secondary; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D015912:Thrombolytic Therapy / Q000379:methods
chemical_list: D000906:Antibodies; D000911:Antibodies, Monoclonal; D004337:Drug Carriers; D011993:Recombinant Fusion Proteins; D011994:Recombinant Proteins; D005337:Fibrin; D010960:Plasminogen Activators